Articles

For diabetic patients with critical limb ischemia, the risk of major amputation and death is “considerable,” researchers report. Study investigator Dr. Giacomo Clerici stated that, “Reduction in the amputation rate among diabetic patients with ischemic diabetic foot is possible” with the extensive use of revascularization by means of both bypass …

Over a 1-year period, treatment with exenatide improved beta-cell function significantly more, and led to greater weight loss, than did insulin glargine, in a study of patients with Type 2 diabetes who had previously been treated with metformin.

Primary care physicians who counsel their African American patients about obesity should remain sensitive to the perceptions of their patients, according to a new report.

With more than 120,000 patients having a bariatric surgery procedure, we now have a database that can help in determining which patients would benefit from the different forms of bariatric surgery.

A couple of weeks ago we had a new product blurb about Cycloset(tm), an old drug with a new indication for diabetes. Many of you wrote to ask me for information on how the medication works and where the idea came from. I had our current PharmD candidate, Robert Fredenrich, …

Treating Type 2 diabetes patients with a cholesterol-lowering drug called fenofibrate cuts the risk of a first diabetes-related limb amputation by 36%, according to a new study published in The Lancet.

All older people should routinely take antihypertensives to prevent cardiovascular disease and stroke, even if they don’t have high blood pressure, according to British researchers.

A team of scientists from Germany and the US found that vitamin C and E supplements may undo the benefits of exercise on diabetes risk and glucose metabolism. It would seem that exercise-induced oxidative stress helps the body defend itself against stress and metabolize carbodydrates more effectively, said the researchers.

New Insights into the Mystery of “High Risk Platelets” from Diabetic Donors Amid emerging concerns that blood platelets donated for transfusion by individuals with Type 2 diabetes may be unsafe, scientists are reporting the first detailed identification and analysis of a group of abnormal proteins in platelets from diabetic donors. …

The results of predictive genetic testing can have a big impact on the intention of parents with Type 2 diabetes to try to prevent the disease in their children, despite the independent effect of the child’s weight on disease risk, according to the results of a study of 189 parents.